跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clofefar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clofefar
Approved
STANDARD
Clofefar
Agio Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
58668553d06b0dcc
Company
Agio Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
58668553d06b0dcc
Drug Approval Philippines Name
Clofefar
Product Name
Clofefar
Registration Number
DRP-978-01
Brand Name
Clofefar
Generic Name
Diclofenac Sodium
Dosage Form
Sustained-Release Tablet
Dosage Strength
100 mg
Manufacturer
Agio Pharmaceuticals Limited
Importer
Ambica International Corporation
Distributor
Diafarm Inc.
Issuance Date
29 June 2024
Expiry Date
19 May 2030
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
58668553d06b0dcc
Type
Standard
Back to Philippines FDA Approvals